Capricor Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Capricor Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Capricor Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Capricor Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $899k | 125k | 7.21 |
| 2025-06-30 | $5.5M | 549k | 9.93 |
| 2025-03-31 | $3.7M | 393k | 9.49 |
| 2024-12-31 | $1.7M | 123k | 13.80 |
| 2024-09-30 | $200k | 13k | 15.21 |
| 2024-06-30 | $41k | 8.7k | 4.77 |
| 2024-03-31 | $10k | 1.5k | 6.79 |
| 2023-03-31 | $19k | 4.4k | 4.22 |
| 2022-06-30 | $102k | 29k | 3.48 |
| 2022-03-31 | $0 | 6.9k | 0.00 |
| 2021-12-31 | $11k | 3.7k | 2.93 |
| 2021-06-30 | $10k | 1.9k | 5.20 |
| 2021-03-31 | $2.0k | 375 | 5.33 |
| 2020-12-31 | $13k | 5.1k | 2.50 |
| 2020-09-30 | $10k | 1.9k | 5.26 |
| 2020-06-30 | $5.0k | 1.0k | 5.00 |
| 2020-03-31 | $2.0k | 1.4k | 1.39 |
| 2019-12-31 | $7.0k | 5.4k | 1.29 |
| 2019-09-30 | $999 | 254 | 3.94 |